MIRM

MIRUM PHARMACEUTICALS INC

MIRM·604749101·US·Common Stock·Healthcare - Biotechnology-Activist

MIRM (MIRUM PHARMACEUTICALS INC) is held by 162 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($641.8M), BlackRock, Inc. ($355.3M), VANGUARD CAPITAL MANAGEMENT LLC ($223.1M). Net institutional sentiment: Mixed.

162
Holders
Avg rating(30 Elite)
$4.1B
Total Value
64% (170)
Fund Consensus
103 buying - 58 selling
MIRMSmart Money Verdict
View all
Held by 162 funds
30 elite
Who's Trading
InsiderPCPeetz ChristopherSell $1.5MJul 6, 2026
InsiderPCPeetz ChristopherSell $512KJul 6, 2026
InsiderPCPeetz ChristopherSell $244KJul 6, 2026
InsiderPCPeetz ChristopherSell $213KJul 6, 2026
InsiderHJHowe JolandaSell $264KJun 17, 2026
InsiderRSRamasastry SairaSell $219KMay 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.7%Apr 27, 2026
InsiderRSRamasastry SairaSell $194KApr 15, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderPCPeetz ChristopherSell $3.8MMar 16, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.9M(+14.5%)$641.8M0.3%+161.57%
43
Increased
3.8M(+5.5%)$355.3M0.0%+172.25%
33
New
2.4M$223.1M0.0%+39.10%
42
Increased
2M(+204.0%)$181.6M0.0%+48.77%
49
Decreased
1.9M(-9.3%)$179.6M0.0%+150.68%
0
Increased
1.7M(+20.9%)$158.7M0.0%+177.54%
36
New
1.4M$132.3M0.0%+39.10%
42
Increased
1.3M(+7.8%)$123.3M0.0%+68.94%
33
Increased
1.3M(+18.5%)$116.4M0.0%+209.58%
35
Increased
1.1M(+25.2%)$97.2M0.0%+223.83%
37
Increased
911,419(+39.0%)$84.2M0.0%+97.36%
39
Increased
774,841(+99.4%)$71.6M0.1%+68.46%
48
New
724,415$66.9M0.0%+39.10%
41
Increased
722,177(+1.2%)$66.7M0.0%+107.74%
30
Increased
714,804(+9.8%)$66M0.0%+253.98%
33
Decreased
671,870(-22.4%)$62.1M0.1%+244.24%
0
Decreased
662,306(-8.6%)$61.2M0.0%+111.14%
0
Increased
584,523(+3.4%)$54M0.0%+132.89%
30
Increased
582,085(+32.6%)$53.8M0.1%+98.53%
38
Unchanged
567,894$52.5M0.2%+239.19%
0

Showing 1-20 of 170

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used